-
Sector Analysis
United Kingdom (UK) Confectionery Market Size and Trend Analysis by Categories and Segment, Distribution Channel, Packaging Formats, Market Share, Demographics and Forecast, 2021-2026
The United Kingdom (UK) confectionery market was valued at GBP7.3 billion ($10 billion) in 2021 and is expected to grow at a CAGR of more than 1% during the forecast period. The UK confectionery market research report provides a comparative analysis of United Kingdom value and volume shares in the global confectionery sector. It offers an overview of the growth at a sector level and analyzes the various categories and distribution channels. Additionally, the report analyzes leading companies in the...
-
Product Insights
Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Phenylalanine 4 hydroxylase or Phenylalanine hydroxylase (PAH) is an enzyme that catalyzes the hydroxylation of the aromatic side-chain of phenylalanine to generate tyrosine. Tyrosine is used to make several types of hormones, certain chemicals that transmit signals in the brain (neurotransmitters), and a pigment called melanin, which gives hair and skin their color. The Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) Development market research report provides an in-depth analysis of Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase...
-
Product Insights
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
N-Sulphoglucosamine Sulphohydrolase is an enzyme encoded by the SGSH gene. This enzyme is involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with Sanfilippo syndrome A, one type of the lysosomal storage disease mucopolysaccaridosis III. The N-Sulphoglucosamine Sulphohydrolase - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for N-Sulphoglucosamine Sulphohydrolase, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule...
-
Product Insights
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alpha L-Iduronidase market pipeline research report provides comprehensive information on the Alpha L-Iduronidase (IDUA or EC 3.2.1.76) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Alpha L-Iduronidase (IDUA or EC 3.2.1.76) targeted therapeutics...